Copyright
©2014 Baishideng Publishing Group Co.
World J Clin Urol. Mar 24, 2014; 3(1): 20-30
Published online Mar 24, 2014. doi: 10.5410/wjcu.v3.i1.20
Published online Mar 24, 2014. doi: 10.5410/wjcu.v3.i1.20
Growth inhibition and apoptosis control of prostate epithelium | [16] |
Decrease of tumor growth, hypercalcemia and skeletal metastases | [17] |
Decrease tumor vessel density | [19] |
Anti-vascular endothelial growth factor effects | [19] |
Inhibit the vascular endothelial growth factor binding to tyrosine kinase receptor Flk-1/KDR expressed by endothelial cells | [19] |
Inhibits the secretion of a matrix metalloproteinase | [20] |
Controls anchorage-independent colony growth of prostate cancer | [21] |
Interaction with IgG and modulating immune function | [57] |
Interaction with CRISP-3 and modulating ion channel regulation | [43] |
Interaction with CRISP-3 to inhibit effects on innate immunity | [43] |
A mediator of natural killer cells and an activator of neutrophils | [53] |
A pH and Ca2+ dependent candidacidal activity | [23] |
- Citation: Karunasinghe N, Bishop K, Murray P, Xu Y, Goudie M, Ng L, Zhu S, Han DY, Ferguson LR, Masters J, Benjamin B, Holmes M. Role of β-microseminoprotein from prostate cancer initiation to recurrence: A mini-review. World J Clin Urol 2014; 3(1): 20-30
- URL: https://www.wjgnet.com/2219-2816/full/v3/i1/20.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i1.20